Dr. Brad Hall is founder of Sengi, a boutique clinical research organization dedicated to helping eye-care professionals run successful investigator-initiated trials. With his PhD in vision science, 50+ peer-reviewed publications, and global conference presentations, he empowers clinicians to transform innovative ideas into published studies that advance patient care. Learn more at www.sengiclinical.com.